Abstract
Molecular disease mechanisms typically constitute abnormalities in the regulation of genes producing many kinds of alterations in the expression levels. To identify disease-altered genes better, we have developed an approach that searches for the genes which present a significant rank alteration in the rank of their expression profiles, by comparing an altered rank with another gene. The approach provides groups of genes and assigns a statistical measure of significance to each pair of genes selected. The method is evaluated using two experimental sets of microarrays. We investigated the possibility of inferring the rank reverse pairs and its possibility in diagnostic application when there is no prior knowledge of the genes belonging to disease, nor about the structure of gene regulatory network. We also show that rank reverse is a very powerful technique to diagnostic disease in the practical application and could be used prior to traditional biomarker discovery.
Keywords: Rank reverse, gene expression, diagnostic approach, chip, disease-altered gene
Current Bioinformatics
Title: Microarray Data Analysis to Find Diagnostic Approach and Identify Families of Disease-Altered Genes Based on Rank-Reverse of Gene Expression
Volume: 4 Issue: 3
Author(s): Wenguang Zhang, Jinquan Li, Rui Su and Wu Jianghong
Affiliation:
Keywords: Rank reverse, gene expression, diagnostic approach, chip, disease-altered gene
Abstract: Molecular disease mechanisms typically constitute abnormalities in the regulation of genes producing many kinds of alterations in the expression levels. To identify disease-altered genes better, we have developed an approach that searches for the genes which present a significant rank alteration in the rank of their expression profiles, by comparing an altered rank with another gene. The approach provides groups of genes and assigns a statistical measure of significance to each pair of genes selected. The method is evaluated using two experimental sets of microarrays. We investigated the possibility of inferring the rank reverse pairs and its possibility in diagnostic application when there is no prior knowledge of the genes belonging to disease, nor about the structure of gene regulatory network. We also show that rank reverse is a very powerful technique to diagnostic disease in the practical application and could be used prior to traditional biomarker discovery.
Export Options
About this article
Cite this article as:
Zhang Wenguang, Li Jinquan, Su Rui and Jianghong Wu, Microarray Data Analysis to Find Diagnostic Approach and Identify Families of Disease-Altered Genes Based on Rank-Reverse of Gene Expression, Current Bioinformatics 2009; 4 (3) . https://dx.doi.org/10.2174/157489309789071039
DOI https://dx.doi.org/10.2174/157489309789071039 |
Print ISSN 1574-8936 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-392X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Trichostatin A - like Hydroxamate Histone Deacetylase Inhibitors as Therapeutic Agents: Toxicological Point of View
Current Medicinal Chemistry Review of PI3K/mTOR Inhibitors Entering Clinical Trials to Treat Triple Negative Breast Cancers
Recent Patents on Anti-Cancer Drug Discovery Regression of Oxidative Stress by Targeting eNOS and Nrf2/ARE Signaling: A Guided Drug Target for Cardiovascular Diseases
Current Topics in Medicinal Chemistry Morphological and Functional Characteristic of Senescent Cancer Cells
Current Drug Targets Glutamine, Glucose and other Fuels for Cancer
Current Pharmaceutical Design The ‘Other’ Telomerase Inhibitors: Non-G-Quadruplex Interactive Agent, Non-Antisense, Non-Reverse Transcriptase Telomerase Inhibitors
Current Medicinal Chemistry - Anti-Cancer Agents Activation of CAR and PXR by Dietary, Environmental and Occupational Chemicals Alters Drug Metabolism, Intermediary Metabolism, and Cell Proliferation
Current Pharmacogenomics and Personalized Medicine Effects of Dietary Polyunsaturated Fatty Acids on Mitochondria
Current Pharmaceutical Design Dendrimers in Photodynamic Therapy
Current Medicinal Chemistry Abnormal Choline Phospholipid Metabolism in Breast and Ovary Cancer:Molecular Bases for Noninvasive Imaging Approaches
Current Medical Imaging Predictive Genomics DNA Profiling for Athletic Performance
Recent Patents on DNA & Gene Sequences Patient-Tailored Treatments with Anti-EGFR Monoclonal Antibodies in Advanced Colorectal Cancer: KRAS and Beyond
Current Cancer Drug Targets Multifaceted Approach to Circadian Rhythm: Redox, Oxidative Stress, Melatonin, Antioxidants, Nitric Oxide, Hypoxia, Anesthetics, Cortisol and Cocaine
Current Chemical Biology Oxazole-Based Compounds As Anticancer Agents
Current Medicinal Chemistry Breast Cancer: Current Developments in Molecular Approaches to Diagnosis and Treatment
Recent Patents on Anti-Cancer Drug Discovery Discovery of Hedgehog Antagonists for Cancer Therapy
Current Medicinal Chemistry Biomarkers of Alzheimer's Disease Risk in Peripheral Tissues; Focus on Buccal Cells
Current Alzheimer Research Novel Therapeutic Approaches to Regulate Human Dihydrofolate Reductase Activity and Expression
Current Enzyme Inhibition Presence of Intratumoral Stem Cells in Breast Cancer Patients with or without BRCA Germline Mutations
Current Cancer Drug Targets The Cyclin-Dependent Kinase Inhibitor p21CDKN1A as a Target of Anti-Cancer Drugs
Current Cancer Drug Targets